IL6 and inflammatory bowel disease: We wondered if the elevated neoplastic risk condition of UC, a type of inflammatory bowel disease whose affected tissues exhibit several proinflammatory cytokines including IL-6, could harbor loss of MSH3 expression similar to our previous findings in CRCs, perhaps as 1 mechanism that could cause DNA damage and elevate neoplastic risk.